Not applicableStudy completedNCT02975752What this trial is testingEGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNAWho this might be right forLung Adenocarcinoma Metastatic University Hospital, Essen 48
Testing effectiveness (Phase 2)Study completedNCT00445848What this trial is testingS0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung CancerWho this might be right forLung Cancer SWOG Cancer Research Network 89
Testing effectiveness (Phase 2)Study completedNCT00970684What this trial is testingBevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer Nathan Pennell, MD, PhD 13
Testing effectiveness (Phase 2)Study completedNCT03728361What this trial is testingNivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine CancerWho this might be right forGrade I Neuroendocrine CarcinomaGrade II Neuroendocrine CarcinomaGrade III Neuroendocrine Carcinoma+9 more Dwight Owen 55
Early research (Phase 1)Study completedNCT00006981What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced CancerWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Not applicableEnded earlyNCT00087191What this trial is testingEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerWho this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Ended earlyNCT01798485What this trial is testingGanetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLCWho this might be right forNon-Small-Cell Lung AdenocarcinomaNon-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV+1 more Synta Pharmaceuticals Corp. 696
Early research (Phase 1)Study completedNCT01131234What this trial is testingGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more National Cancer Institute (NCI) 20
Not applicableLooking for participantsNCT05837767What this trial is testingRadiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueWho this might be right forInvasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT02864992What this trial is testingTepotinib Phase II in NSCLC Harboring MET Alterations (VISION)Who this might be right forAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET AmplificationLung Adenocarcinoma Stage IIIB/IV EMD Serono Research & Development Institute, Inc. 337
Not applicableStudy completedNCT03154190What this trial is testingHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerWho this might be right forAcute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more Stanford University 128
Not applicableNot Yet RecruitingNCT07392073What this trial is testingPeripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLCWho this might be right forNon-Small Cell Lung CancerLung AdenocarcinomaLung Squamous Cell Carcinoma+3 more Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 80
Early research (Phase 1)Study completedNCT00004095What this trial is testingIrinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+3 more Northwestern University 38
Early research (Phase 1)Ended earlyNCT04432207What this trial is testingIMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung CancerNon Small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV+3 more Imugene Limited 24
Early research (Phase 1)Study completedNCT02318771What this trial is testingRadiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung CancerWho this might be right forHead and Neck Squamous Cell CarcinomaMetastatic Renal Cell CancerRecurrent Head and Neck Carcinoma+6 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 41
Early research (Phase 1)Ended earlyNCT06158958What this trial is testingAssess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid TumorsWho this might be right forSolid Tumors AbbVie 27
Not applicableStudy completedNCT00897793What this trial is testingGrowth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+2 more Vanderbilt-Ingram Cancer Center 25
Not applicableStudy completedNCT04493827What this trial is testingDistribution and Prognostic Impact of Oncogenic Drivers in Metastatic Lung Adenocarcinoma : a Retrospective Monocentric Study in Nancy University Hospital CenterWho this might be right forAdenocarcinoma of Lung Stage IVAdenocarcinoma of Lung, Response to Tyrosine Kinase Inhibitor in, Somatic Central Hospital, Nancy, France 114
Testing effectiveness (Phase 2)Study completedNCT00550537What this trial is testingProteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer Vanderbilt-Ingram Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT00005850What this trial is testingCombination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerWho this might be right forAnxiety DisorderDepressionFatigue+1 more Alliance for Clinical Trials in Oncology 21